XML 13 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2017
Dec. 31, 2016
Current assets    
Cash and cash equivalents $ 725
Receivables 3,757 3,757
Total current assets 4,482 3,757
Fixed assets, net 305
Investment in equity method investee 452,538 454,062
Total assets 457,020 458,124
Current liabilities    
Accounts payable and accrued liabilities 201,398 196,731
Due to related parties 11,750 11,750
Loans payable 3,712
Convertible notes payable, net of discount 446,813 555,464
Derivitive liability 4,811,248 870,921
Total current liabilities 5,471,209 1,638,578
Total liabilities 5,471,209 1,638,578
Stockholders' deficit    
Preferred stock, 9,933,333 shares authorized, $0.0001 par value, 4,000,000 issued and outstanding 400 400
Common stock; $0.0001 par value; 250,000,000 shares authorized; 2,644,193,397 and 199,404,940 shares issued and outstanding as of March 31, 2017 and December 31, 2016, respectively. 264,420 19,941
Additional paid-in capital 12,926,284 6,238,344
Accumulated deficit (18,205,300) (7,439,146)
Total stockholders' deficit (5,014,188) (1,180,454)
Total liabilities and stockholders' deficit 457,020 458,124
Series B Preferred Stock [Member]    
Stockholders' deficit    
Preferred stock, 9,933,333 shares authorized, $0.0001 par value, 4,000,000 issued and outstanding $ 7 $ 7